Background Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes
Clostridioides difficile infection (CDI). It has been recognised as a leading cause of …

Clostridium difficile infection (CDI) continues to affect patients in hospitals and communities
worldwide. The spectrum of clinical disease ranges from mild diarrhoea to toxic megacolon …

Background For over four decades, Clostridium difficile has been a significant enteric
pathogen of humans. It is associated with the use of antimicrobials that generally disrupt the …

Spore formation and germination are essential for the bacterial pathogen Clostridioides
difficile to transmit infection. Despite the importance of these developmental processes to the …

Fecal microbiota transplantation (FMT) has evolved into a robust and efficient means for
treating recurrent Clostridium difficile infection (CDI). Our narrative review looks at the donor …

The Gram-positive anaerobic bacterium Clostridioides difficile (CD) can produce intense
exotoxins, contributing to nosocomial infections, and it is the most common cause of health …

Fluorescent proteins are powerful reporters in biology, but most require O2 for chromophore
maturation, making them inherently difficult to use in anaerobic bacteria. Clostridium difficile …

Clostridium difficile is widely publicised as a problem in the health-care system. Disruption of
the normal gut microbiota by antibiotic therapy allows C. difficile to colonise the colon. On …

The recent discovery of the same Clostridioides difficile ribotypes associated with human
infection in a broad range of environments, animals and foods, coupled with an ever …

This document discusses, among other things, receiving a plurality of donor fecal samples
from a plurality of donors and storing and indexing each respective donor fecal samples …